Caas Capital Management LP Regeneron Pharmaceuticals, Inc. Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $591,549 - $694,239	-994 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1.67 Million - $1.97 Million	-3,526 Reduced 78.01%	994 $555,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $2.01 Million - $2.47 Million	4,500 Added 22500.0%	4,520 $2.14 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $325,244 - $413,426	-680 Reduced 97.14%	20 $10,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $345,324 - $450,744	700 New	700 $437,000

1,426

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.